Trends in pancreatic cancer incidence, prevalence, and survival outcomes by histological subtypes: a retrospective cohort study

被引:0
作者
Lei, Sen [1 ]
Mao, Yize [1 ]
Yang, Qiuxia [2 ]
Yan, Honghong [3 ]
Wang, Jun [1 ]
机构
[1] Sun Yat Sen Univ, Guangdong Prov Clin Res Ctr Canc, Dept Pancreatobiliary Surg, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Guangdong,, Peoples R China
[2] Sun Yat Sen Univ, Guangdong Prov Clin Res Ctr Canc, Dept Radiol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Guangdong Prov Clin Res Ctr Canc, Dept ICU, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Peoples R China
关键词
pancreatic cancer; incidence; prevalence; survival; Joinpoint; EPIDEMIOLOGY; CARCINOMA; NEOPLASMS;
D O I
10.1093/gastro/goaf030
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Pancreatic cancer (PC) is a heterogeneous disease with various histological and molecular subtypes. This study aimed to provide updated epidemiological estimates, survival outcomes, and treatment information for PC based on histological subtypes in the USA.Methods Data from the US Cancer Statistics and Surveillance, Epidemiology, and End Results (SEER)-17 databases (2000-2020) were used, including adults aged >= 20 years who were diagnosed with PC. The trends of incidence and prevalence by histological types were calculated by using the Joinpoint Regression model. Survival by histological type was analysed by using Kaplan-Meier curves and log-rank tests for group comparisons.Results Overall, the age-adjusted PC incidence per 100,000 increased from 9.54 to 12.05 in SEER-17 and from 9.75 to 12.19 in the US Cancer Statistics between 2001 and 2019. A further SEER-17 study comprised 113,681 PC cases that were sorted by histologic type between 2000 and 2020. The incidence per 100,000 of invasive intraductal papillary mucinous neoplasm (IPMN) and invasive mucinous cystic neoplasm (MCN) decreased (IPMN from 0.67 to 0.20 and MCN from 0.05 to 0.01) whereas that of other histological subtypes increased. Survival analysis indicated the best outcomes for solid pseudopapillary tumors and the poorest for squamous cell carcinoma. At the localized stage, the proportion of surgery in the treatment modalities varied depending on the biological behavior; the proportion of surgery for pancreatic neuroendocrine tumor was the highest and that for pancreatic ductal adenocarcinoma (PDAC) was the lowest. At the distant metastasis stage, a chemotherapy-based regimen remained the primary treatment of PDAC, pancreatic neuroendocrine tumor, and IPMN.Conclusions PC incidence and prevalence have been increasing. The incidence of IPMN and MCN decreased whereas that of other subtypes increased. Treatment distribution varies among subtypes and stages.
引用
收藏
页数:9
相关论文
共 22 条
[1]   Increasing Pancreatic Cancer Incidence in Young Women in the United States: A Population-Based Time-Trend Analysis, 2001-2018 [J].
Abboud, Yazan ;
Samaan, Jamil S. ;
Oh, Janice ;
Jiang, Yi ;
Randhawa, Navkiran ;
Lew, Daniel ;
Ghaith, Jenan ;
Pala, Pranav ;
Leyson, ChristineAnn ;
Watson, Rabindra ;
Liu, Quin ;
Park, Kenneth ;
Paski, Shirley ;
Osipov, Arsen ;
Larson, Brent K. ;
Hendifar, Andrew ;
Atkins, Katelyn ;
Nissen, Nicholas N. ;
Li, Debiao ;
Pandol, Stephen J. ;
Lo, Simon K. ;
Gaddam, Srinivas .
GASTROENTEROLOGY, 2023, 164 (06) :978-+
[2]  
[Anonymous], Cancer of the Prostate-Cancer Stat Facts Surveillance, Epidemiology, and End Results Program
[3]   415 Patients with Adenosquamous Carcinoma of the Pancreas: A Population-Based Analysis of Prognosis and Survival [J].
Boyd, Casey A. ;
Benarroch-Gampel, Jaime ;
Sheffield, Kristin M. ;
Cooksley, Catherine D. ;
Riall, Taylor S. .
JOURNAL OF SURGICAL RESEARCH, 2012, 174 (01) :12-19
[4]   Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States [J].
Dasari, Arvind ;
Shen, Chan ;
Halperin, Daniel ;
Zhao, Bo ;
Zhou, Shouhao ;
Xu, Ying ;
Shih, Tina ;
Yao, James C. .
JAMA ONCOLOGY, 2017, 3 (10) :1335-1342
[5]  
Department of Health and Human Services Centers for Disease Control and Prevention and National Cancer Institute, 2023, United States Cancer Statistics
[6]   Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data [J].
Gordon-Dseagu, Vanessa L. ;
Devesa, Susan S. ;
Goggins, Michael ;
Stolzenberg-Solomon, Rachael .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2018, 47 (02) :427-439
[7]   Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer [J].
Huang, Junjie ;
Lok, Veeleah ;
Ngai, Chun Ho ;
Zhang, Lin ;
Yuan, Jinqiu ;
Lao, Xiang Qian ;
Ng, Kelvin ;
Chong, Charing ;
Zheng, Zhi-Jie ;
Wong, Martin C. S. .
GASTROENTEROLOGY, 2021, 160 (03) :744-754
[8]   Pancreatic adenosquamous carcinoma: A population level analysis of epidemiological trends and prognosis [J].
Huang, Zhihao ;
Wang, Jiakun ;
Zhang, Rongguiyi ;
He, Aoxiao ;
Luo, Shuaiwu ;
Wu, Rongshou ;
Xiong, Jianghui ;
Li, Min ;
Jin, Tao ;
Li, Enliang ;
Wu, Linquan ;
Liao, Wenjun .
CANCER MEDICINE, 2023, 12 (08) :9926-9936
[9]   Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma [J].
Latenstein, Anouk E. J. ;
van der Geest, Lydia G. M. ;
Bonsing, Bert A. ;
Koerkamp, Bas Groot ;
Mohammad, Nadia Haj ;
de Hingh, Ignace H. J. T. ;
de Meijer, Vincent E. ;
Molenaar, Izaak Q. ;
van Santvoort, Hjalmar C. ;
van Tienhoven, Geertjan ;
Verheij, Joanne ;
Vissers, Pauline A. J. ;
de Vos-Geelen, Judith ;
Busch, Olivier R. ;
van Eijck, Casper H. J. ;
van Laarhoven, Hanneke W. M. ;
Besselink, Marc G. ;
Wilmink, Johanna W. .
EUROPEAN JOURNAL OF CANCER, 2020, 125 :83-93
[10]   Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies [J].
Lee, Lingaku ;
Ito, Tetsuhide ;
Jensen, Robert T. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (12) :1029-1050